AVIPRO IBD XTREME
AVIPRO IBD XTREME
Not authorised
- Infectious bursal disease virus, strain V217 (intermediate plus), Live
Product identification
Medicine name:
AVIPRO IBD XTREME
Active substance:
- Infectious bursal disease virus, strain V217 (intermediate plus), Live
Target species:
-
Chicken
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain V217 (intermediate plus), Live1.50/log 10 50% embryo infective dose1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate for use in drinking water
Withdrawal period by route of administration:
-
In drinking water use
-
Chicken
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Lohmann Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Lohmann Animal Health GmbH
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 120292
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Romanian (PDF)
Published on: 7/11/2023
Updated on: 11/11/2023